Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yara Maria Machlah"'
Autor:
Hilal Bhat, Gregor Zaun, Thamer A. Hamdan, Judith Lang, Tom Adomati, Rosa Schmitz, Sarah-Kim Friedrich, Michael Bergerhausen, Lamin B. Cham, Fanghui Li, Murtaza Ali, Fan Zhou, Vishal Khairnar, Vikas Duhan, Tim Brandenburg, Yara Maria Machlah, Maximilian Schiller, Arshia Berry, Haifeng Xu, Jörg Vollmer, Dieter Häussinger, Beatrice Thier, Aleksandra A. Pandyra, Dirk Schadendorf, Annette Paschen, Martin Schuler, Philipp A. Lang, Karl S. Lang
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Immune activation within the tumor microenvironment is one promising approach to induce tumor regression. Certain viruses including oncolytic viruses such as the herpes simplex virus (HSV) and non-oncolytic viruses such as the lymphocytic choriomenin
Externí odkaz:
https://doaj.org/article/75601dc4b0134284b6d488ec8fac6ac6
Autor:
Tom Adomati, Lamin B. Cham, Thamer A. Hamdan, Hilal Bhat, Vikas Duhan, Fanghui Li, Murtaza Ali, Elisabeth Lang, Anfei Huang, Eyad Naser, Vishal Khairnar, Sarah-Kim Friedrich, Judith Lang, Justa Friebus-Kardash, Michael Bergerhausen, Maximilian Schiller, Yara Maria Machlah, Florian Lang, Dieter Häussinger, Stanislav Ferencik, Cornelia Hardt, Philipp A. Lang, Karl S. Lang
Publikováno v:
Cell Reports, Vol 30, Iss 11, Pp 3671-3681.e5 (2020)
Summary: Infections can result in a temporarily restricted unresponsiveness of the innate immune response, thereby limiting pathogen control. Mechanisms of such unresponsiveness are well studied in lipopolysaccharide tolerance; however, whether mecha
Externí odkaz:
https://doaj.org/article/adb0a8a0b0c54307b1e06bb9c186cfaa
Autor:
Lamin B. Cham, Sarah-Kim Friedrich, Tom Adomati, Hilal Bhat, Maximilian Schiller, Michael Bergerhausen, Thamer Hamdan, Fanghui Li, Yara Maria Machlah, Murtaza Ali, Vikas Duhan, Karl Sebastian Lang, Justa Friebus-Kardash, Judith Bezgovsek
Publikováno v:
Pharmaceuticals, Vol 12, Iss 4, p 142 (2019)
Background: Tamoxifen (TAM) is an estrogen-receptor antagonist, widely used in the adjuvant treatment of early stage estrogen-sensitive breast cancer. Several studies have revealed new biological targets of TAM that mediate the estrogen receptor inde
Externí odkaz:
https://doaj.org/article/11e9b93aa45744f6942fd55ac1261b48
Autor:
Hilal, Bhat, Gregor, Zaun, Thamer A, Hamdan, Judith, Lang, Tom, Adomati, Rosa, Schmitz, Sarah-Kim, Friedrich, Michael, Bergerhausen, Lamin B, Cham, Fanghui, Li, Murtaza, Ali, Fan, Zhou, Vishal, Khairnar, Vikas, Duhan, Tim, Brandenburg, Yara Maria, Machlah, Maximilian, Schiller, Arshia, Berry, Haifeng, Xu, Jörg, Vollmer, Dieter, Häussinger, Beatrice, Thier, Aleksandra A, Pandyra, Dirk, Schadendorf, Annette, Paschen, Martin, Schuler, Philipp A, Lang, Karl S, Lang
Publikováno v:
Frontiers in Immunology
Immune activation within the tumor microenvironment is one promising approach to induce tumor regression. Certain viruses including oncolytic viruses such as the herpes simplex virus (HSV) and non-oncolytic viruses such as the lymphocytic choriomenin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4bd041c2f69c24262cefd9c453d00d91
https://duepublico2.uni-due.de/receive/duepublico_mods_00072909
https://duepublico2.uni-due.de/receive/duepublico_mods_00072909
Autor:
Sarah-Kim Friedrich, Michael Bergerhausen, Yara Maria Machlah, Hilal Bhat, Vikas Duhan, Philipp A. Lang, Cornelia Hardt, Stanislav Ferencik, Maximilian Schiller, Thamer A. Hamdan, Judith Lang, Florian Lang, Elisabeth Lang, Karl S. Lang, Fanghui Li, Tom Adomati, Eyad Naser, Anfei Huang, Dieter Häussinger, Lamin B. Cham, Vishal Khairnar, Justa Friebus-Kardash, Murtaza Ali
Publikováno v:
Cell Reports, Vol 30, Iss 11, Pp 3671-3681.e5 (2020)
Summary: Infections can result in a temporarily restricted unresponsiveness of the innate immune response, thereby limiting pathogen control. Mechanisms of such unresponsiveness are well studied in lipopolysaccharide tolerance; however, whether mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99a649afdbe65b308b27c2fd486b9ecb
https://pubmed.ncbi.nlm.nih.gov/32187540
https://pubmed.ncbi.nlm.nih.gov/32187540
Autor:
Duhan, Judith Bezgovsek, Kardash J, Flatz L, Karl S. Lang, Pa Lang, Hilal Bhat, Sarah-Kim Friedrich, Halime Kalkavan, Krolik M, Yara Maria Machlah, Fan Zhou, Michael Bergerhausen, Cornelia Hardt, Tim Brandenburg, Maximilian Schiller
With the integration of PD-1 and CTLA-4 targeting immune checkpoint blockade into cancer treatment regimes, the anti-tumoral cytotoxicity of tumor-specific CD8+T cells is well established. However, while the unresponsiveness of CD8+T cells against bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b27f050216fa55a4776d79a8ee908ddd